Internal Medicine, Rheumatology · Modesto, CA
NPI
1629246228
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
600 Coffee Rd
Modesto, CA, 95355
Phone (209) 521-6097
Groups this clinician bills Medicare through
Medicare paid, 2024
$282K
21,944 services
Medicare patients, 2024
883
Average age 72
Drug cost, 2024
$7.8M
9,532 prescriptions
Company payments, 2025
$3,413
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hajra I Tily was code J1010 (injection, methylprednisolone acetate, 1 mg), 8,116 times for 87 patients. In total Hajra I Tily billed 21,944 services in 38 codes, and Medicare paid $282K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 8,116 | 87 | $0.10 | $828 |
| 99214 Office E&M - Established | Office | 1,281 | 770 | $91.59 | $117K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 598 | 518 | $12.98 | $7,760 |
| 99215 Office E&M - Established | Office | 137 | 118 | $140.41 | $19K |
| 99204 Office E&M - New | Office | 134 | 134 | $124.95 | $17K |
| 20610 Joint Injection | Office | 96 | 66 | $54.18 | $5,201 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 52 | 33 | $6.77 | $352 |
| 96372 Injection Administration | Office | 39 | 32 | $11.12 | $434 |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 14 | $93.20 | $3,169 |
| 99223 Hospital E&M - Initial | Facility | 28 | 22 | $136.17 | $3,813 |
| 99205 Office E&M - New | Office | 24 | 24 | $162.99 | $3,912 |
| 20600 Joint Injection | Office | 22 | 16 | $27.90 | $614 |
| 20605 Joint Injection | Office | 13 | 11 | $31.11 | $404 |
By year: 2022 $224K for 3,861 services; 2023 $294K for 11,650 services; 2024 $282K for 21,944 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hajra I Tily prescribed most often to Medicare patients was Prednisone, with 1,686 prescriptions and refills. In total Hajra I Tily wrote 9,532 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,686 | 2,862 | 360 | $15K |
| Hydroxychloroquine Sulfate Generic | 1,273 | 2,654 | 299 | $50K |
| Methotrexate Methotrexate Sodium | 1,026 | 2,228 | 250 | $33K |
| Sulfasalazine Generic | 458 | 1,036 | 126 | $19K |
| Leflunomide Generic | 349 | 774 | 94 | $19K |
| Folic Acid Generic | 347 | 836 | 89 | $3,791 |
| Tizanidine Hcl Generic | 330 | 375 | 93 | $8,947 |
| Humira(Cf) Pen Adalimumab | 223 | 223 | 26 | $1.5M |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 220 | 508 | 62 | $3,055 |
| Gabapentin Generic | 210 | 399 | 52 | $4,509 |
| Cyclobenzaprine Hcl Generic | 188 | 361 | 59 | $4,127 |
| Omeprazole Generic | 186 | 452 | 57 | $2,660 |
| Baclofen Generic | 164 | 277 | 51 | $3,218 |
| Sulindac Generic | 160 | 261 | 39 | $4,228 |
| Diclofenac Sodium Generic | 158 | 254 | 44 | $6,110 |
Brand drugs: 1,538 claims; generic drugs: 7,964 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hajra I Tily $3,413 ($3,413 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $905.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 52 | $905 |
| Janssen Biotech, Inc. JNJ | 27 | $432 |
| Novartis Pharmaceuticals Corporation NVS | 21 | $419 |
| Amgen Inc. AMGN | 24 | $370 |
| UCB, Inc. UCB.BR | 11 | $317 |
| Pfizer Inc. PFE | 11 | $263 |
| GlaxoSmithKline, LLC. GSK | 13 | $262 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $190 |
| Lilly USA, LLC LLY | 3 | $85.33 |
| Genentech USA, Inc. ROG.SW | 3 | $78.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.